Scarica l'app Stockscreener
17.90
2.29%
0.40
Dopo l'orario di chiusura:
18.14
0.24
+1.34%
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
Using Bollinger Bands to evaluate MBX Biosciences Inc.Weekly Earnings Recap & Accurate Intraday Trading Signals - newser.com
Is it too late to sell MBX Biosciences Inc.Dollar Strength & Safe Swing Trade Setup Alerts - newser.com
How MBX Biosciences Inc. stock reacts to bond yieldsWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Using AI based signals to follow MBX Biosciences Inc.Portfolio Growth Summary & Accurate Entry and Exit Point Alerts - newser.com
MBX Biosciences Inc. stock momentum explainedIPO Watch & Risk Managed Investment Strategies - newser.com
Massive Stock Purchase by MBX Biosciences Director! - TipRanks
Goldman Sachs Group Inc. Has $112,000 Stock Holdings in MBX Biosciences, Inc. $MBX - MarketBeat
Analyzing MBX Biosciences Inc. with multi timeframe chartsWeekly Stock Analysis & Free Fast Gain Swing Trade Alerts - newser.com
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum - GlobeNewswire
Precision Peptide Innovator MBX Biosciences Featured at Stifel 2025 Cardiometabolic Forum - Stock Titan
Is MBX Biosciences Inc. stock a defensive play in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Will MBX Biosciences Inc. bounce back from current supportMarket Performance Report & AI Powered Market Entry Strategies - newser.com
Developing predictive dashboards with MBX Biosciences Inc. dataJuly 2025 Outlook & Daily Chart Pattern Signals - newser.com
MBX Biosciences stock down on pricing upsized public offering at $18.00 per share - MSN
Is MBX Biosciences Inc a good long term investmentTrading Volume Trends & Learn the Basics of Investing in 5 Days - earlytimes.in
How MBX Biosciences Inc. stock compares to market leadersEarnings Risk Report & AI Enhanced Trading Alerts - newser.com
MBX Biosciences Inc Stock Analysis and ForecastProtective Put Strategies & Unlock Long-Term Capital Growth Ideas - earlytimes.in
MBX, uniQure among biotechs raising nine-figure sums: Public Equity Report - biocentury.com
MBX Biosciences Announces Public Offering Agreement - TipRanks
MBX Biosciences Reports Promising Phase 2 Trial Results - MSN
MBX Biosciences (NASDAQ:MBX) Shares Gap DownTime to Sell? - MarketBeat
MBX Biosciences Shares Drop Following Upsized Public Offering Pricing - MSN
MBX Biosciences stock falls after pricing upsized public offering By Investing.com - Investing.com Nigeria
MBX Biosciences stock falls after pricing upsized public offering - Investing.com
Stitch Fix Posts Q4 Results, Joins Transocean, MBX Biosciences And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
MBX Biosciences slips after $200 mln stock offering - TradingView
MBX Biosciences Prices Upsized $200 Million Common Stock Offering - MarketScreener
MBX Biosciences Announces Pricing of Upsized Public Offering - The Manila Times
Transcript : MBX Biosciences, Inc.Special Call - MarketScreener
$199.9 Million Raise: Biotech MBX Biosciences Prices Upsized Public Offering of 11.1M Shares at $18 - Stock Titan
MBX Biosciences announces pricing of upsized public offering of 11,108,055 shares at $18.00 per share - MarketScreener
MBX Biosciences: Mizuho Raises Price Target to $56 Amidst Outper - GuruFocus
Mizuho Increases MBX Biosciences (NYSE:MBX) Price Target to $56.00 - MarketBeat
Wall Street Analysts Think MBX Biosciences, Inc. (MBX) Could Surge 88.55%: Read This Before Placing a Bet - MSN
MBX Biosciences stock price target raised to $56 from $38 at Mizuho - Investing.com
MBX Biosciences price target raised to $56 from $38 at Mizuho - TipRanks
MBX Biosciences stock price target raised to $84 from $44 at Guggenheim - Investing.com Canada
MBX Biosciences (NYSE:MBX) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
MBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Announces Target Price $56 - 富途牛牛
MBX Biosciences eases after stock offering announced - TradingView
Citizens JMP Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $61 - 富途牛牛
MBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for CanvuparatideHas The Bull Case Changed? - Yahoo Finance
MBX Biosciences reports positive Phase 2 results for hypoparathyroidism drug - Investing.com Nigeria
AutoZone, Micron Technology And 3 Stocks To Watch Heading Into Tuesday - Benzinga
2.95%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):